{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T03:40:10Z","timestamp":1709523610186},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,3]]},"DOI":"10.7759\/cureus.55448","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T03:06:00Z","timestamp":1709521560000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Cholecystitis Camouflaging Cholangiocarcinoma"],"prefix":"10.7759","author":[{"given":"Sreshta","family":"Paranji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rathnamitreyee","family":"Vegunta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Pellegrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33476","article-title":"The global, regional, and national burden of gallbladder and biliary tract cancer and its attributable risk factors in 195 countries and territories, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"127","author":"Ouyang G","year":"2021","unstructured":"Ouyang G, Liu Q, Wu Y, et al.. The global, regional, and national burden of gallbladder and biliary tract cancer and its attributable risk factors in 195 countries and territories, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study 2017. Cancer. 2021, 127:2238-50. 10.1002\/cncr.33476","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_160831","article-title":"Biliary tract cancer: epidemiology, radiotherapy, and molecular profiling","volume":"35","author":"Bridgewater JA","year":"2016","unstructured":"Bridgewater JA, Goodman KA, Kalyan A, Mulcahy MF. Biliary tract cancer: epidemiology, radiotherapy, and molecular profiling. Am Soc Clin Oncol Educ Book. 2016, 35:e194-203. 10.1200\/EDBK_160831","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28529","article-title":"Aspirin use and the risk of cholangiocarcinoma","volume":"64","author":"Choi J","year":"2016","unstructured":"Choi J, Ghoz HM, Peeraphatdit T, et al.. Aspirin use and the risk of cholangiocarcinoma. Hepatology. 2016, 64:785-96. 10.1002\/hep.28529","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2013.5137","article-title":"Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis","volume":"149","author":"Mavros MN","year":"2014","unstructured":"Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg. 2014, 149:565-74. 10.1001\/jamasurg.2013.5137","journal-title":"JAMA Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1993.01420200045008","article-title":"Outcomes after curative resections of cholangiocarcinoma","volume":"128","author":"Nagorney DM","year":"1993","unstructured":"Nagorney DM, Donohue JH, Farnell MB, Schleck CD, Ilstrup DM. Outcomes after curative resections of cholangiocarcinoma. Arch Surg. 1993, 128:871-7; discussion 877-9. 10.1001\/archsurg.1993.01420200045008","journal-title":"Arch Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.3.947","article-title":"Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors","volume":"15","author":"Klempnauer J","year":"1997","unstructured":"Klempnauer J, Ridder GJ, von Wasielewski R, Werner M, Weimann A, Pichlmayr R. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol. 1997, 15:947-54. 10.1200\/JCO.1997.15.3.947","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3182822277","article-title":"Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes","volume":"257","author":"Aoba T","year":"2013","unstructured":"Aoba T, Ebata T, Yokoyama Y, et al.. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes. Ann Surg. 2013, 257:718-25. 10.1097\/SLA.0b013e3182822277","journal-title":"Ann Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199611000-00007","article-title":"Surgical treatment in proximal bile duct cancer. A single-center experience","volume":"224","author":"Pichlmayr R","year":"1996","unstructured":"Pichlmayr R, Weimann A, Klempnauer J, Oldhafer KJ, Maschek H, Tusch G, Ringe B. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg. 1996, 224:628-38. 10.1097\/00000658-199611000-00007","journal-title":"Ann Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199604000-00007","article-title":"Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma","volume":"223","author":"Su CH","year":"1996","unstructured":"Su CH, Tsay SH, Wu CC, et al.. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg. 1996, 223:384-94. 10.1097\/00000658-199604000-00007","journal-title":"Ann Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle J","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, et al.. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010, 362:1273-81. 10.1056\/NEJMoa0908721","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh DY","year":"2022","unstructured":"Oh DY, Ruth He A, Qin S, et al.. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evid. 2022, 1:EVIDoa2200015. 10.1056\/EVIDoa2200015","journal-title":"NEJM Evid"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00727-4","article-title":"Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Kelley RK","year":"2023","unstructured":"Kelley RK, Ueno M, Yoo C, et al.. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023, 401:1853-65. 10.1016\/S0140-6736(23)00727-4","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00606","article-title":"Tucatinib and trastuzumab for previously treated human epidermal growth factor receptor 2-positive metastatic biliary tract cancer (SGNTUC-019): a phase II basket study","volume":"41","author":"Nakamura Y","year":"2023","unstructured":"Nakamura Y, Mizuno N, Sunakawa Y, et al.. Tucatinib and trastuzumab for previously treated human epidermal growth factor receptor 2-positive metastatic biliary tract cancer (SGNTUC-019): a phase II basket study. J Clin Oncol. 2023, 41:5569-78. 10.1200\/JCO.23.00606","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/225819-a-case-of-cholecystitis-camouflaging-cholangiocarcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T03:06:04Z","timestamp":1709521564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/225819-a-case-of-cholecystitis-camouflaging-cholangiocarcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,3]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.55448","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,3]]}}}